Dermatology, Procedural Dermatology · Buffalo Grove, IL
NPI
1134118987
Since 2005
Specialty
Dermatology, Procedural Dermatology
Code 207NS0135X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
600 W Lake Cook Rd, Suite 110
Buffalo Grove, IL, 60089
Phone (847) 459-6611
Groups this clinician bills Medicare through
Medicare paid, 2024
$644K
12,080 services
Medicare patients, 2024
1,759
Average age 76
Drug cost, 2024
$948K
1,575 prescriptions
Company payments, 2025
$2,919
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael H Fretzin was code 17003 (destruction skin lesion), 3,238 times for 491 patients. In total Michael H Fretzin billed 12,080 services in 86 codes, and Medicare paid $644K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,238 | 491 | $5.10 | $17K |
| 99213 Office E&M - Established | Office | 1,447 | 1,082 | $63.78 | $92K |
| 88305 Surgical Pathology Examination | Office | 932 | 567 | $52.44 | $49K |
| 17000 Destruction Skin Lesion | Office | 842 | 643 | $41.00 | $35K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 554 | 122 | $0.66 | $367 |
| 11102 Skin Biopsy | Office | 551 | 499 | $67.51 | $37K |
| 99212 Office E&M - Established | Office | 366 | 311 | $38.91 | $14K |
| 99203 Office E&M - New | Office | 279 | 279 | $75.60 | $21K |
| 17110 Destruction Skin Lesion | Office | 246 | 215 | $80.53 | $20K |
| 11103 Skin Biopsy | Office | 216 | 139 | $40.26 | $8,696 |
| 77401 Conventional Radiation Treatment | Office | 172 | 12 | $33.98 | $5,845 |
| 99202 Office E&M - New | Office | 132 | 132 | $47.57 | $6,280 |
| 96372 Injection Administration | Office | 123 | 83 | $10.15 | $1,249 |
| 17004 Destruction Skin Lesion | Office | 88 | 69 | $127.24 | $11K |
| 99214 Office E&M - Established | Office | 84 | 56 | $80.56 | $6,767 |
By year: 2022 $595K for 11,383 services; 2023 $748K for 13,247 services; 2024 $644K for 12,080 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 932 | 567 | $52.44 | $49K |
| 88304 Surgical Pathology Examination | 20 | 19 | $33.32 | $666 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael H Fretzin prescribed most often to Medicare patients was Triamcinolone Acetonide, with 367 prescriptions and refills. In total Michael H Fretzin wrote 1,575 Medicare prescriptions that cost $948K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 367 | 409 | 251 | $3,834 |
| Ketoconazole Generic | 161 | 164 | 90 | $2,708 |
| Clobetasol Propionate Generic | 105 | 117 | 76 | $5,418 |
| Valacyclovir Valacyclovir Hcl | 92 | 118 | 37 | $1,603 |
| Minoxidil Generic | 79 | 203 | 33 | $898 |
| Humira(Cf) Pen Adalimumab | 67 | 67 | Under 11 | $481K |
| Doxycycline Hyclate Generic | 62 | 86 | 27 | $2,791 |
| Alclometasone Dipropionate Generic | 48 | 50 | 39 | $1,966 |
| Minocycline Hcl Generic | 42 | 43 | 22 | $741 |
| Fluocinonide Generic | 40 | 42 | 31 | $1,129 |
| Betamethasone Dipropionate Generic | 36 | 39 | 26 | $1,387 |
| Prednisone Generic | 29 | 37 | 16 | $232 |
| Metronidazole Generic | 28 | 28 | 18 | $2,131 |
| Clindamycin Phosphate Generic | 28 | 30 | 14 | $894 |
| Hydrocortisone Generic | 27 | 27 | 22 | $173 |
Brand drugs: 159 claims; generic drugs: 1,416 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael H Fretzin $2,919 ($2,919 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $579.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 30 | $579 |
| UCB, Inc. UCB.BR | 13 | $476 |
| Regeneron Healthcare Solutions, Inc. REGN | 15 | $473 |
| Genzyme Corporation SNY | 8 | $186 |
| Janssen Biotech, Inc. JNJ | 6 | $168 |
| Pfizer Inc. PFE | 11 | $164 |
| Lilly USA, LLC LLY | 11 | $161 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $122 |
| Botanix SB Inc | 5 | $101 |
| Organon LLC OGN | 8 | $96.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.